| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,752 | 5,753 | 5,258 | 7,113 | | Cost of Revenue | 7,817 | 3,413 | 4,029 | 5,274 | | | Gross Profit | 2,936 | 2,340 | 1,229 | 1,839 | | | Operating Expenses | | Research Development | 196 | 352 | 278 | (804) | | Selling General and Administrative | 6,288 | 4,768 | 4,993 | 5,712 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 1,066 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,549) | (2,781) | (4,042) | (4,136) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14 | 11 | 29 | 202 | | Earnings Before Interest And Taxes | (3,534) | (2,769) | (4,013) | (3,934) | | Interest Expense |
-
|
-
|
-
| (23) | | Income Before Tax | (3,534) | (2,769) | (4,013) | (3,911) | | Income Tax Expense | (100) |
-
| (105) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,434) | (2,769) | (3,908) | (3,911) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,434) | (2,769) | (3,908) | (3,911) | | Preferred Stock And Other Adjustments | (343) | (343) | (343) | (343) | | | Net Income Applicable To Common Shares | ($3,777) | ($3,112) | ($4,250) | ($4,254) |
|
0.03% Nasdaq 0.00%
Income Statement
